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Abstract 
BACKGROUND: The spread of phytocomplex application and justification of its selective effects on tumour cells 
(mainly due to the presence of flavonoids) require research of its cytotoxic and immunomodulatory activity.  
AIM: The goal was to study the direct cytotoxic effect of the phytocomplex and its modulating effect on the 
cytotoxic activity of the donor's mononuclear blood cells in in vitro experiments.  
METHODS: The phytocomplex was a dry extract from marsh cinquefoil, creeping alfalfa and common hop; its 
main active ingredients were flavonoids. Transplantable monolayer cultures of lung adenocarcinoma, colorectal 
cancer, erythroblastic leukaemia, and fibroblasts were used as target cells. The cytotoxic activity was assessed 
using a cytotoxic test based on the selective ability to live cells to reduce MTT (3-[4, 5-dimethyltriazol-2-yl]-2, 5 
diphenyltetrazolium bromide) to formazan in mitochondria. Quantitative determination of formazan was performed 
using spectrophotometry.  
RESULTS: A direct cytotoxic effect of the phytocomplex in concentrations of at least 2.5 mg/ml on tumour cells 
has been established. Its modulating effect on the cytotoxic activity of mononuclear blood cells at a concentration 
of 0.05 mg/ml was shown. The phytocomplex in doses of 0.25 and 0.5 mg/ml increased the killer activity of the 
mononuclear cells in a diseased person's blood, but did not affect these blood cells in a healthy donor. Incubation 
of lymphocytes with a phytocomplex for 24 hours increased the cytotoxic activity of mononuclear cells by 20-25%.  
CONCLUSION: The direct cytotoxic effect of the phytocomplex and its modulating effect on the cytotoxic activity 
of mononuclear blood cells in model experiments in vitro have been established. 
 
 
 
Introduction 
 
Natural products in dietary sources including 
fruits, vegetables, and spices, which consist of 
biologically active components such as phytosterols, 
flavonoids, saponins, lycopene, triperpenoids, and 
many others, are assumed to have anticancer 
properties [1]. Interest in flavonoids (polyphenols of 
plant origin) is currently largely due to their anti-
inflammatory, antioxidant, antitumor, 
immunomodulatory, antimicrobial and other types of 
activity [2], [3], [4] [5].  
The most relevant, for purposes of the 
practical application of flavonoids, are their 
immunomodulating and antitumor properties [6], [7], 
[8], [9], [10], [11]. The phytocomplex under study was 
a dry extract from marsh cinquefoil, creeping alfalfa 
and common hop. It contained a variety of biologically 
active substances, including flavonoids, coumestans, 
polysaccharides, steroids, essential oils, tannins, 
hydroxycinnamic and phenol carboxylic acids, 
essential amino acids, vitamins, and mineral 
components, all of which makes it useful in medicine. 
The main active ingredients of the phytocomplex were 
flavonoids [12]. Recent studies have shown the 
promise and the need for further study of the cytotoxic 
and immunomodulatory activity of the phytocomplex 
for use together with physiotherapeutic methods [13]. 
The goal of this work was to investigate the 
direct cytotoxic effect of the phytocomplex and its 
modulating effect on the cytotoxic activity of the 
donor's mononuclear blood cells (MNCs) in in vitro 
experiments. 
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Material and Methods 
 
The phytocomplex that was used in the study 
was a dry extract from leaves and roots of marsh 
cinquefoil, leaves of creeping alfalfa and multiple fruits 
(or cones) of common hop (TS 9375-021-00003938-
11 “Dry extract of marsh cinquefoil, creeping alfalfa 
and common hop (phytocomplex)” [14]. The main 
flavonoids present in the phytocomplex are shown in 
Figure 1. The flavonoid composition of the raw 
materials of the used medicinal plants was compatible 
and balanced in terms of the content of flavones, 
flavonols and their glycosides, isoflavones, which 
should have a positive impact on the cytotoxic and 
immunomodulatory activity of the phytocomplex. The 
predominant flavonoids were quercetin, rutin and 
isoflavones: biochanin A, genistein, daidzein. 
 
Figure 1: Structural formulas of the main flavonoids of the 
phytocomplex 
 
A cytotoxic test, based on the selective ability 
to live cells to reduce MTT (3-[4, 5-dimethyltriazol-2-
yl]-2, 5 diphenyltetrazolium bromide, Sigma, USA) to 
formazan in mitochondria, was used to study the 
direct cytotoxic effect of the phytocomplex. 
Quantitative determination of formazan was 
performed using spectrophotometry. Based on the 
optical density data, the number of dead target cells 
(i.e. cytotoxic activity) was calculated. 
The following human cell lines were used: 
lung adenocarcinoma (LAC, A-549) and colorectal 
cancer (Colo), a model of solid tumours, erythroblastic 
leukaemia (K-562), a model of hemoblastosis and 
normal fibroblasts (obtained from the laboratory of 
tumour cells genetics of the Blokhin Federal Medical 
Research Center for Oncology) were used as target 
cells. Target cells were applied in 96-well flat-
bottomed microplates in quantity of 2 x 10
6
 cells per 
well in 100 μl of the working culture medium (WCM): 
RPMI-1640 (No. FSR 2007/00859, Chumakov 
Institute of Poliomyelitis and Viral Encephalitis, 
Russia) with 5% fetal calf serum. In the experimental 
series, working solutions of the phytocomplex were 
added to the target cells. The final concentrations of 
the phytocomplex in the wells were 5 mg/ml, 2.5 
mg/ml, 0.5 mg/ml, 0.05 mg/ml, 0.005 mg/ml. In the 
control series, a saline solution was added to the 
target cells. The total volume of the solution in the 
wells was 200 μl.  
Target cells and effectors were placed in a 
carbon-oxygen incubator (Binder C 150 CO2 
incubator, Germany) at 37°C for 18 hours. At the end 
of the experiment, 10 μl of a sterile MTT dye solution 
was added to each well. Plates protected with 
aluminium foil were placed in a dark place at 37°C for 
four hours, then centrifuged for five minutes. The 
supernatant was removed with a pipette without 
disturbing the cell pellet. Formazan crystals were 
dissolved in dimethyl sulfoxide, which was added into 
the well to bring the volume up to 200 μl. The 
complete dissolution of the formazan crystals was 
achieved with stirring on a nutator for 5-15 minutes 
using an invertoscope to control the process. 
The optical density was measured 
immediately after the complete dissolution of the 
formazan crystals using a spectrophotometer (Jasco 
V-730, Japan) at a wavelength of 540 nm. 
To study the modulating effect of the 
phytocomplex on the cytotoxic activity of MNCs, 
extract concentrations that did not have a direct 
cytotoxic effect on the target cells were used. MNCs 
were isolated from the blood samples of six donors, 
obtained from the blood transfusion department of the 
Blokhin Federal Medical Research Center for 
Oncology. Six primary patients with stage II lung 
cancer (three) and colon cancer (three) without signs 
of metastasis were included in the study.  
Heparinised blood (15 units/ml) was diluted 
twice with medium 199 (No. ФСР 2011/10969, 
Chumakov Institute of Poliomyelitis and Viral 
Encephalitis, Russia), layered on ficoll-verografin 
(density 1.077 g/cm
3
) in the 2:1 ratio and centrifuged 
for 30 minutes. MNCs were sampled using a Pasteur 
pipette and washed three times with medium 199 for 
ten minutes. The concentration of the suspension in 
WCM was adjusted to 5 x 10
6
 cells/ml. In the 
experiment with donors, MNCs, LAC, Colo, K-562 
cells and fibroblasts were used as target cells. For 
cancer patients, MNCs investigated only NK activity 
on the NK-sensitive K-562 cells. The ratio of target 
cells and effectors was 1:5. 
Statistical processing of the results was 
carried out using the SPSS. Statistics. v17. 
Multilingual-EQUiNOX Software (SPSS Inc.). 
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Results 
 
The results of the experiment for the study of 
direct cytotoxic action of the phytocomplex on target 
cells are presented in Figure 2. 
 
Figure 2: Cytotoxic activity of the phytocomplex (* Р < 0.05, ** Р < 
0.01) 
 
It was found that the addition of working 
solutions of the phytocomplex at a concentration of 5 
mg/ml to the target cells resulted in the death of a 
significant proportion of tumour cells (72-82%). A two-
fold decrease in the effective concentration (2.5 
mg/ml) caused lysis of 23-28% of tumour cells. At 
lower concentrations from 0.5 to 0.005 mg/ml, the 
cytotoxicity was 4-12%, which was not significantly 
different from the data for the control series. 
Extract concentrations that did not have a 
direct cytotoxic effect on target cells were used for 
further studies of the modulating effect of the 
phytocomplex on the cytotoxic activity of MNCs. The 
results of the experiment are presented in Figure 3. 
 
Figure 3: The modulating influence of the phytocomplex on the 
cytotoxic activity of MNCs (* Р < 0.05) 
It has been shown that out of the working 
solutions of the phytocomplex with concentrations 
ranging from 0.001 to 0.5 mg/ml only the dose of 0.05 
mg/ml had a significant stimulating effect on the 
antitumor cytotoxic activity of MNCs (53-57%, LAC, 
Colo and K-562 cells were used). Increase of the 
concentration to 0.5 mg/ml did not lead to an increase 
in the spontaneous activity of MNCs, and a further 
increase of the dose could have a direct cytotoxic 
effect on tumour cells. The obtained data 
corresponded to the data on the effect of other well-
known immunomodulators, such as Interleukin-1 and 
Interleukin-2, although the latter do not have a dose-
dependent effect. No effect of the phytocomplex on 
the cytotoxic activity of MNCs was shown when using 
fibroblasts as target cells. 
Additionally, the modulating effect of the 
phytocomplex on the killer activity of MNCs of a 
healthy donor and a cancer patient was investigated 
(Figure 4). Cells of K-562 cell culture, which are 
sensitive to natural killers, were used as target cells. 
Working solutions with phytocomplex concentrations 
of 0.5 and 0.25 mg/ml did not have a direct cytotoxic 
effect on K-562 cells. It was established that the 
phytocomplex in concentrations of 0.5 and 0.25 mg/ml 
does not have a significant modulating effect on the 
cytotoxic activity of MNCs of a healthy donor, but 
increases the killer activity of MNCs of a cancer 
patient by 15-18% compared to the control. 
 
Figure 4: The modulating influence of the phytocomplex on the 
cytotoxic activity of MNCs of a healthy donor and a diseased person 
when tested using K-562 cells (* Р < 0.05) 
 
It is known that the maximum effect of 
classical immunomodulators is achieved after 24-48 
hours. Therefore, we incubated lymphocytes with the 
phytocomplex for 24 hours at 37°C (Figure 5). 
Experiments have shown that incubation 
increases the cytotoxic activity of donor MNCs by 20-
25% compared with the control. 
 
Figure 5: The modulating influence of the phytocomplex on the 
cytotoxic activity of MNCs of a healthy donor when tested using K-
562 cells after incubation for 24 hours (* Р < 0.05) 
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In a special series of experiments, the 
modulating effect of the phytocomplex on the cytotoxic 
activity of MNCs was studied using different ratios of 
target cells and MNCs: 1:1, 1:2 and 1:5 (Figure 6). In 
the control series, a solution of the phytocomplex was 
not added. 
It was established that the phytocomplex 
increases the cytotoxic activity of MNCs by 20-29% 
compared with the control, regardless of the target 
cells to MNCs ratio. 
 
Figure 6: The modulating effect of the phytocomplex at a 
concentration of 0.05 mg/ml on the cytotoxic activity of MNCs of a 
healthy donor when tested using K-562 cells with different MNCs to 
target cells ratios (* Р < 0.05) 
 
 
 
Discussion 
 
For the first time, the cytotoxic activity of the 
phytocomplex was studied using transplantable 
monolayer cultures of lung adenocarcinoma, 
colorectal cancer, erythroblastic leukaemia and 
fibroblasts in vitro experiments. It has been 
established that the phytocomplex has a direct 
cytotoxic effect on tumour cells in concentrations of 
5.0 and 2.5 mg/ml. 
The modulating effect of the phytocomplex on 
the cytotoxic activity of MNCs at a concentration of 
0.05 mg/ml (53-57%) was registered when using cell 
cultures of lung adenocarcinoma, colorectal cancer 
and erythroblastic leukaemia. An increase in the 
concentration of the phytocomplex did not lead to an 
increase in the spontaneous activity of blood 
mononuclear cells. 
It has been established that the phytocomplex 
in concentrations of 0.25 and 0.5 mg/ml increases the 
killer activity of the MNCs of a diseased person by 15-
18%, but does not affect the cytotoxic activity of the 
blood mononuclear cells of a healthy donor. 
It has been shown that incubation of 
lymphocytes with phytocomplex for 24 hours 
increases the cytotoxic activity of mononuclear cells 
by 20-25%. Variations in the ratio of target cells and 
blood mononuclear cells did not significantly affect the 
immunomodulating effect of the phytocomplex. 
In conclusion, the direct cytotoxic effect of the 
phytocomplex and its modulating effect on the 
cytotoxic activity of mononuclear blood cells in model 
experiments in vitro have been established. 
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